Skip to content

Clinical trials

Terminated Carcinoma, Non-Small-Cell Lung trials in Singapore

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Carcinoma, Non-Small-Cell Lung Status: Terminated Country / region: Singapore Clear all

29 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20051
20072
20082
20092
20141
20154
20162
20173
20183
20194
20213
20221
20231

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Terminated29

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals14
Bayer2
National Cancer Centre, Singapore2
AVEO Pharmaceuticals, Inc.1
Astellas Pharma Global Development, Inc.1
Blueprint Medicines Corporation1
Celgene1
ETOP IBCSG Partners Foundation1
GlaxoSmithKline1
Merck KGaA, Darmstadt, Germany1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Carcinoma, Non-Small-Cell Lung29
Carcinoma, Renal Cell4
Carcinoma3
Melanoma3
Squamous Cell Carcinoma of Head and Neck3
Colorectal Neoplasms2
Esophageal Squamous Cell Carcinoma2
Neoplasm Metastasis2
Neoplasms2
Ovarian Neoplasms2

Trials

Showing 1 to 25 of 29. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.